TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Prevention of hypothermia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of D-dimer levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction of F1 + 2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reliability of pelvic floor dysfunction questionnaires
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive functions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean language scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change from baseline in NPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TVF rate
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Cost savings per patient per day
Endpoint domain: Resource use
Primary endpoint: Latency of analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of motor blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean changes of total IPSS from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 2 or higher breast fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: mycological clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: marked improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Exclusive breastfeeding rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Infant seroconversions
Endpoint domain: Adverse events/effects
Primary endpoint: overall injuries
Endpoint domain: Adverse events/effects
Primary endpoint: overuse injuries
Endpoint domain: Adverse events/effects
Primary endpoint: severe injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Re-attendance rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total serum cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total fat intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite of death, MI, stroke or transient ischemic attack, or major or life-threatening bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Major or life-threatening bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: PEFR decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Asthma symptoms interference
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: disaster awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: disaster readiness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sleep efficiency index (SEI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wakefulness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rate at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Probability of detecting the first ID-NAT-reactive unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial function (measured as EDV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Times to recurrence of mood events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CES-D score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cu/Zn-SOD content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cu/Zn-SOD mRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of plasma salbutamol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (AEs) rate
Endpoint domain: Adverse events/effects
Primary endpoint: frequency of apnea attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: time of oxygen use and NCPAP support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Decreased IMVC force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced PPT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased mean of DOMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of sweat patches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Side effects of sweat patches
Endpoint domain: Adverse events/effects
Primary endpoint: Practicality of use in outpatient clinics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in urinary GAGs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General Health Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sleep disorders
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Interfibular gap dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: repigmentation response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatal and non-fatal embolism
Endpoint domain: Mortality/survival
Primary endpoint: myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emotional support needs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Autonomic nerve function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine days per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of migraine pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIT-6 questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Left Ventricular (LV) function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain relief from injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: straining
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: sensation of incomplete evacuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improved skin hydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in flaking and lichenification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Differentiation between low-grade and high-grade recurrent astrocytomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reported abstinence and not seeking alcohol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: cardiac events
Endpoint domain: Mortality/survival
Primary endpoint: hard events
Endpoint domain: Mortality/survival
Primary endpoint: childbirth satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of developing cholesteatoma or perforation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ear outcomes
Primary endpoint: Rate of achieving bilaterally normal hearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Hearing outcomes
Primary endpoint: Cardiac survival
Endpoint domain: Mortality/survival
Primary endpoint: Pharmacokinetic parameters of thalidomide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for detection of pancreatic duct dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity for detection of pancreatic duct abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean amplitude of glycemic excursion (MAGE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Standard deviation (SD) of blood glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total effective rates of cardiac function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post‐treatment total scale score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: posttest physical activity frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial lipid mobilization and oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neonatal Infant Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of vaginal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of gastrointestinal side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of care
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: risk of death or lung transplant
Endpoint domain: Mortality/survival
Primary endpoint: Rates of sclerotomy closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time spent in the euglycemic range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time spent in the hypoglycemic range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma prolactin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Ratio of TYR+PHE:BCAA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decision-making performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of sites exhibiting AST levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean hip-knee-ankle value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in total score of the ABC scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Integration and embedding of RESTORE into everyday life
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Resting energy expenditure (REE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: biochemical recurrence free survival
Endpoint domain: Mortality/survival
Primary endpoint: biochemical recurrence
Endpoint domain: Mortality/survival
Primary endpoint: metastasis events
Endpoint domain: Mortality/survival
Primary endpoint: Decrease in TNFα concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in IgM concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Compression of perceived depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with RTOG hippocampal avoidance constraints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: real-time maximum pain scores during insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: one-year survival
Endpoint domain: Mortality/survival
Primary endpoint: hospital-free days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: AUC(0-168)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean relative bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WONCA-quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean foveal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best-corrected logMAR visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Neutrophil Count (ANC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Participation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Safety with skill performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-rated general health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: QTcF interval changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean improvement in IIEF-EF domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate for penetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate for intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of meal-induced fundus relaxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: new bone formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: lack of immunological potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 12-month self-reported abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biochemical verification of cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adjusted cessation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean MES counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent hot flushes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coefficient of friction on the skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal infection prevention
Endpoint domain: Mortality/survival
Primary endpoint: maternal outbreak prevention
Endpoint domain: Adverse events/effects
Primary endpoint: Polyp Detection Rate (PDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of PH
Endpoint domain: Mortality/survival
Primary endpoint: warfarin knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: endogenous rate of appearance of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: protein balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cannulation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: self-estimated mental health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-estimated quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: surgical bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hospitalization risk
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Rehospitalization risk
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: median time of fistula closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: closure rates of fistulas within the first 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of cerebral infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Good clinical recovery 12 months after aSAH
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sublingual dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Retinal glycocalyx dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: TER(alb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in type 1 diabetes risk score from baseline to 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDL cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid and lipoprotein outcomes
Primary endpoint: plasma triglycerides levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid and lipoprotein outcomes
Primary endpoint: LDL particle diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid and lipoprotein outcomes
Primary endpoint: Ovarian and uterine volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Endocrine function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: trigeminal detection thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: trigeminal intensity estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: summated responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum aspartate aminotransferase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean sensor glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: induction-vaginal delivery interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean dose of misoprostol required for induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean duration of oxytocin augmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome event rate
Endpoint domain: Mortality/survival
Primary endpoint: Protocol completion rate
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: compliance with laboratory monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily rate of nonsevere hypoglycemia events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean relative improvement in MSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRS 0 to 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: ease of intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Relative postprandial lipid response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effective rate of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PERMP total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serious infections
Endpoint domain: Mortality/survival
Primary endpoint: Time to passage of flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Postoperative abdominal distention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in prevalence of neck pain cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean physical fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Development of ulcerative oral mucositis (OM)
Endpoint domain: Mortality/survival
Primary endpoint: Mouth pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difficulty swallowing severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between homeopaths
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Screening reliability for SPC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sip duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Pressure Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Guideline Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Antihypertensive Medications Prescribed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medication misuse behavior
Endpoint domain: Adverse events/effects
Primary endpoint: Communication with health care providers
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: PUD treatment success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes